Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report

Creative Commons License

Borekci E.

AFRICAN HEALTH SCIENCES, vol.19, no.2, pp.2290-2293, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 2
  • Publication Date: 2019
  • Doi Number: 10.4314/ahs.v19i2.55
  • Journal Name: AFRICAN HEALTH SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2290-2293
  • Yozgat Bozok University Affiliated: Yes

Abstract

Rivaroxaban is one of the new anti-coagulants that inhibit Factor Xa and rarely cause rectus sheath hematoma and retroperitoneal haemorrhage which are uncommon, life-threatening complications. Here is a case of an elderly patient on rivaroxaban therapy for the stroke prevention in non-valvular atrial fibrillation who developed rectus sheath hematoma and retroperitoneal bleeding.